Tryptophan Hydroxylase as Novel Target for the Treatment of Depressive Disorders

被引：60

作者：

Matthes, Susann ^{[1
]}

Mosienko, Valentina ^{[1
]}

Bashammakh, Saleh ^{[1
]}

Alenina, Natalia ^{[1
]}

Bader, Michael ^{[1
]}

机构：

[1] Max Delbruck Ctr Mol Med, DE-13125 Berlin, Germany

来源：

PHARMACOLOGY | 2010年 / 85卷 / 02期

关键词：

Serotonin; Depression; Schizophrenia; Antidepressants; HUMAN TRYPTOPHAN-HYDROXYLASE-2 GENE; SEROTONIN-RELATED GENES; SINGLE NUCLEOTIDE POLYMORPHISM; BIPOLAR AFFECTIVE-DISORDER; OF-FUNCTION MUTATION; ISOFORM TPH2 GENE; SUICIDAL-BEHAVIOR; NO ASSOCIATION; MAJOR DEPRESSION; MOUSE MODEL;

D O I：

10.1159/000279322

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Serotonin (5-HT) is a monoamine implicated in a variety of physiological processes that functions either as a neurotransmitter or as a peripheral hormone. Pharmacological and genetic studies in humans and experimental animals have shown that 5-HT is important for the pathophysiology of depressive disorders. The 5-HT system is thus already a main target for the therapy of these diseases. The peripheral and cerebral biosynthesis of 5-HT is initiated by two distinct tryptophan hydroxylases: TPH1 and TPH2. This duality of the serotonergic system and the existence of a brain-specific TPH isoform provide a promising new target for pharmacological intervention with higher selectivity and specificity and, therefore, possibly with reduced side effects and increased efficiency. This paper summarizes the data which support TPH2 as novel drug target and discusses strategies for its pharmacological exploitation. Copyright (C) 2010 S. Karger AG, Basel

引用

页码：95 / 109

页数：15

共 50 条

[21] The Treatment of Depressive Disorders in Children and Adolescents
Dolle, Kathrin
Schulte-Koerne, Gerd
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2013, 110 (50): : 854 - +
[22] Auricular Treatment of Maternal Depressive Disorders
Soliman, Nader
MEDICAL ACUPUNCTURE, 2019, 31 (05) : 259 - 266
[23] Association with tryptophan hydroxylase 2 gene polymorphisms and autism spectrum disorders in Korean families
Yang, So Young
Yoo, Hee Jeong
Cho, In Hee
Park, Mira
Kim, Soon Ae
NEUROSCIENCE RESEARCH, 2012, 73 (04) : 333 - 336
[24] Association between tryptophan hydroxylase gene polymorphism (A218C) and schizophrenic disorders
Hong, CJ
Tsai, SJ
Wang, YC
SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 59 - 63
[25] Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms
Comai, Stefano
Nunez, Nicolas
Atkin, Tobias
Ghabrash, Maykel F.
Zakarian, Rita
Fielding, Allan
Saint-Laurent, Marie
Low, Nancy
Sauber, Garrett
Ragazzi, Eugenio
Hillard, Cecilia J.
Gobbi, Gabriella
BMC MEDICINE, 2024, 22 (01)
[26] Neuroimaging with radiotracers in depressive disorders and antidepressant treatment
Hesse, S.
Sabri, O.
Brockmann, H.
Biersack, H. J.
Boecker, H.
NERVENHEILKUNDE, 2009, 28 (10) : 719 - 726
[27] Serotonergic drugs in the treatment of depressive and anxiety disorders
Den Boer, JA
Bosker, FJ
Slaap, BR
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2000, 15 (05) : 315 - 336
[28] Novel Psychopharmacology for Depressive Disorders
Fornaro, Michele
De Berardis, Domenico
Anastasia, Annalisa
Fusco, Andrea
MAJOR DEPRESSIVE DISORDER: RETHINKING AND UNDERSTANDING RECENT DISCOVERIES, 2021, 1305 : 449 - 461
[29] Association study of the tryptophan hydroxylase 1 gene with major depressive disorder in three ethnic groups of the Malaysian population
Lian, Lay-Hoong
Loke, Ai-Chin
Zainal, Nor Z.
Mohamed, Zahurin
ASIAN BIOMEDICINE, 2013, 7 (01) : 105 - 112
[30] Functional Properties of Missense Variants of Human Tryptophan Hydroxylase 2
McKinney, Jeffrey A.
Turel, Banu
Winge, Ingeborg
Knappskog, Per M.
Haavik, Jan
HUMAN MUTATION, 2009, 30 (05) : 787 - 794

← 1 2 3 4 5 →